Group IIA sPLA2 concentration in NAF samples from breast cancer patients was positively correlated with the tumor stage, with higher expression seen in stages III and IV, as compared to stage I and II cancers [83]. This evidence concerns the gene PLA2G2A and breast carcinoma.